ARCHIVES

Zydelig Tablets Approved For Three Blood Cancers

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

STI-571 Effects Are Lasting Against GI Stromal Tumors

July 26, 2002

NCI Evaluating PDQ Evaluation

September 1, 1989

In Brief: Ross, Harvey To Lead Cancer Center Group; NCI Director In Office By Aug. 1, Varmus Says

May 19, 1995

Federal Science: NASA, NCI Explore Research On Sensor Technologies

August 13, 1999

In Brief: CRCC, One Of The 21 Comprehensive Centers, To Close Up; Steckel New AACI President

January 30, 1981

New Agents, New Approaches Benefit Treatment Of Advanced Lung Cancer

August 29, 2003